The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

Autor: Ronald Pallota, Ana Silvia Gouvêa de Lima, Maria de Lourdes Lopes Ferrari Chauffaille, Maria Isabel A. Madeira, Elvira Deolinda Rodrigues Pereira Velloso, Marcos Roberto Pedron Oltramari, Peter J. M. Valk, Rosane Bittencourt, Arnold Ganser, Eduardo Magalhães Rego, Luisa C A Koury, Nancy Berliner, Lorena Lobo de Figueiredo-Pontes, Fabiola Traina, Marcia Higashi, Fernanda Borges da Silva, Rodrigo Miguel Bendlin, Katia B Pagnano, Priscila Santos Scheucher, Bob Löwenberg, Juan L Coelho-Silva
Přispěvatelé: Hematology
Rok vydání: 2017
Předmět:
Zdroj: Blood advances, 1, 86-89. American Society of Hematology
ISSN: 2473-9529
Popis: Conventional cytogenetic analysis remains mandatory at the initial evaluation of a patient with acute myeloid leukemia (AML). Molecular testing by reverse transcriptase polymerase chain reaction for recurring rearrangements and NPM1, FLT3, and CEBPA mutational screening have been used in routine
Databáze: OpenAIRE